Pneumococcal vaccination in patients with psoriasis or atopic dermatitis

• Conditions: L40.0; L20.0; Psoriasis vulgaris; Besnier prurigo

• Registration Number: DRKS00017801
• Lead Sponsor: niversitätsmedizin Göttingen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-08-26
• Results First Posted: 2021-08-01
• Study Completion: 2021-08-25
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 425

Inclusion Criteria

Ability to consent
- Signed and dated consent form
- Patients with physician-diagnosed psoriasis or atopic dermatitis
- Age: at least 18 years

Exclusion Criteria

Any member of the study team who is directly or indirectly involved in the study

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The prevalence of pneumococcal vaccination among patients with Psoriasis and atopic dermatitis according to the vaccination certificate

Secondary Outcome Measures

Name	Time	Method
evel of pneumococcal antibodies,<br>Prevalence of further vaccinations,<br>Individual reasons against vaccinations, Changes of vaccination and perceptions of vaccinations